Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $33.0 million.

  • Maxcyte's Total Non-Current Liabilities fell 587.73% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.0 million, marking a year-over-year decrease of 587.73%. This contributed to the annual value of $32.9 million for FY2024, which is 803.65% down from last year.
  • According to the latest figures from Q3 2025, Maxcyte's Total Non-Current Liabilities is $33.0 million, which was down 587.73% from $28.8 million recorded in Q2 2025.
  • In the past 5 years, Maxcyte's Total Non-Current Liabilities ranged from a high of $35.8 million in Q4 2023 and a low of $13.1 million during Q3 2021
  • In the last 5 years, Maxcyte's Total Non-Current Liabilities had a median value of $31.3 million in 2024 and averaged $28.8 million.
  • As far as peak fluctuations go, Maxcyte's Total Non-Current Liabilities skyrocketed by 14473.56% in 2022, and later tumbled by 1009.87% in 2023.
  • Over the past 5 years, Maxcyte's Total Non-Current Liabilities (Quarter) stood at $20.8 million in 2021, then soared by 50.99% to $31.4 million in 2022, then rose by 14.22% to $35.8 million in 2023, then decreased by 8.04% to $32.9 million in 2024, then increased by 0.09% to $33.0 million in 2025.
  • Its last three reported values are $33.0 million in Q3 2025, $28.8 million for Q2 2025, and $30.3 million during Q1 2025.